Plunkett Research Online: Humanigen

HUMANIGEN (HGEN) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side-.....


HUMANIGEN

Ticker: HGEN
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 650 243-3100
Fax:
Address: 533 Airport Blvd., Ste. 400
Burlingame, CA 94005 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Cameron DurrantCEO/Chairman of the Board/Director
Timothy MorrisCFO/COO/Director
See More
Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side-.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture